Skip to main content
Back
Watch Compare

Enveric Biosciences, Inc.

Data quality: 83%
ENVB
NASDAQ Manufacturing Chemicals
$1.95
▼ $0.02 (-1.02%)
6 months return
—
Momentum
Neutral
ROE
-311.01%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-311.01%
Below sector avg (-54.49%)
ROIC-245.77%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio4.60
Interest Coverage-82777.81

Valuation

PE (TTM)
-0.44
Above sector avg (-1.50)
P/B Ratio1.11
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -8.14 M

Price History

Financial Trends

Analyst Price Target

No analyst coverage available

Earnings Surprises

EPS
Reported Estimate
Q12024 Q22024 Q32024 Q42024
Reported -$109.80 -$45.00 -$43.20 -$2.03
Estimate -$139.50 -$99.00 — -$2.76
Surprise +21.29% +54.55% — +26.38%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -311.01% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -8.77 M
ROE -311.01% ROA -221.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.14 M
ROIC -245.77% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 4.60
Debt / Equity N/A Current Ratio 4.60
Interest Coverage -82777.81 Asset Turnover N/A
Working Capital 3.26 M Tangible Book Value 3.41 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.44 · EV/EBITDA: N/A
P/E Ratio -0.44 Forward P/E N/A
P/B Ratio 1.11 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -212.49%
Market Cap 3.83 M Enterprise Value 3.83 M

Per Share

EPS: -36.24 · FCF/Share: -4.31
EPS (Diluted TTM) -36.24 Revenue / Share N/A
FCF / Share -4.31 OCF / Share -4.31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 92.81% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 92.81%
SBC-Adj. FCF -9.10 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -8.77 M -9.57 M -17.29 M -48.98 M -18.47 M
EPS (Diluted) -36.24 -19.04 -8.09 — —
Gross Profit — — — — —
Operating Income -8.77 M -9.63 M -16.45 M -64.62 M -27.42 M
EBITDA — — — — —
R&D Expenses 2.78 M 2.84 M 7.25 M 4.79 M 8.03 M
SG&A Expenses — — — 20.50 M —
D&A 200,858.0 337,489.0 343,982.0 656,643.0 327,910.0
Interest Expense -106.0 219.0 3,708.0 10,316.0 5,249.0
Income Tax 8,930.0 8,930.0 28,913.0 -7.45 M -1.49 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 5.10 M 3.08 M 4.30 M 26.72 M 19.55 M
Total Liabilities — — — 4.41 M 4.00 M
Shareholders' Equity 4.18 M 1.59 M 1.96 M 22.31 M 14.67 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 4.94 M 2.73 M 3.58 M 17.74 M 18.43 M
Current Liabilities 918,400.0 1.49 M 2.34 M 2.08 M 4.00 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -0.4 -1.5
P/B 1.1 1.6
ROE % -311.0 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock
PSIL logo PSIL AdvisorShares Psychedelics ETF
0.76% weight